Source link : https://www.newshealth.biz/health-news/molecular-stool-testing-could-cut-colonoscopies-by-15-41/
Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and mortality. It might also reduce colonoscopies by an estimated 15%-41%. The greatest reduction would likely be achieved by annual FIT-based surveillance, especially with FIT FOB-Gold at a threshold of at least […]
Author : News Health
Publish date : 2024-10-21 13:23:04
Copyright for syndicated content belongs to the linked Source.